-
Je něco špatně v tomto záznamu ?
Shaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures
K. Karakostis, R. Fåhraeus,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
BioMedCentral
od 2001-12-01
BioMedCentral Open Access
od 2001
Directory of Open Access Journals
od 2001
Free Medical Journals
od 2001
PubMed Central
od 2001
Europe PubMed Central
od 2001
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2001-01-01
Medline Complete (EBSCOhost)
od 2001-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
Springer Nature OA/Free Journals
od 2001-12-01
- MeSH
- genetická predispozice k nemoci MeSH
- interakční proteinové domény a motivy MeSH
- lidé MeSH
- messenger RNA genetika MeSH
- nádorové supresorové proteiny genetika metabolismus MeSH
- nádorový supresorový protein p53 genetika metabolismus MeSH
- nádory genetika metabolismus patologie MeSH
- proteiny vázající RNA metabolismus MeSH
- regulace genové exprese u nádorů * MeSH
- stanovení celkové genové exprese MeSH
- transkriptom MeSH
- vazba proteinů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Structured RNA regulatory motifs exist from the prebiotic stages of the RNA world to the more complex eukaryotic systems. In cases where a functional RNA structure is within the coding sequence a selective pressure drives a parallel co-evolution of the RNA structure and the encoded peptide domain. The p53-MDM2 axis, describing the interactions between the p53 tumor suppressor and the MDM2 E3 ubiquitin ligase, serves as particularly useful model revealing how secondary RNA structures have co-evolved along with corresponding interacting protein motifs, thus having an impact on protein - RNA and protein - protein interactions; and how such structures developed signal-dependent regulation in mammalian systems. The p53(BOX-I) RNA sequence binds the C-terminus of MDM2 and controls p53 synthesis while the encoded peptide domain binds MDM2 and controls p53 degradation. The BOX-I peptide domain is also located within p53 transcription activation domain. The folding of the p53 mRNA structure has evolved from temperature-regulated in pre-vertebrates to an ATM kinase signal-dependent pathway in mammalian cells. The protein - protein interaction evolved in vertebrates and became regulated by the same signaling pathway. At the same time the protein - RNA and protein - protein interactions evolved, the p53 trans-activation domain progressed to become integrated into a range of cellular pathways. We discuss how a single synonymous mutation in the BOX-1, the p53(L22 L), observed in a chronic lymphocyte leukaemia patient, prevents the activation of p53 following DNA damage. The concepts analysed and discussed in this review may serve as a conceptual mechanistic paradigm of the co-evolution and function of molecules having roles in cellular regulation, or the aetiology of genetic diseases and how synonymous mutations can affect the encoded protein.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005909
- 003
- CZ-PrNML
- 005
- 20200525093327.0
- 007
- ta
- 008
- 200511s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12885-019-6118-y $2 doi
- 035 __
- $a (PubMed)31519161
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Karakostis, Konstantinos $u Université Paris 7, INSERM UMR 1131, 27 Rue Juliette Dodu, 75010, Paris, France. chem898@yahoo.gr.
- 245 10
- $a Shaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures / $c K. Karakostis, R. Fåhraeus,
- 520 9_
- $a Structured RNA regulatory motifs exist from the prebiotic stages of the RNA world to the more complex eukaryotic systems. In cases where a functional RNA structure is within the coding sequence a selective pressure drives a parallel co-evolution of the RNA structure and the encoded peptide domain. The p53-MDM2 axis, describing the interactions between the p53 tumor suppressor and the MDM2 E3 ubiquitin ligase, serves as particularly useful model revealing how secondary RNA structures have co-evolved along with corresponding interacting protein motifs, thus having an impact on protein - RNA and protein - protein interactions; and how such structures developed signal-dependent regulation in mammalian systems. The p53(BOX-I) RNA sequence binds the C-terminus of MDM2 and controls p53 synthesis while the encoded peptide domain binds MDM2 and controls p53 degradation. The BOX-I peptide domain is also located within p53 transcription activation domain. The folding of the p53 mRNA structure has evolved from temperature-regulated in pre-vertebrates to an ATM kinase signal-dependent pathway in mammalian cells. The protein - protein interaction evolved in vertebrates and became regulated by the same signaling pathway. At the same time the protein - RNA and protein - protein interactions evolved, the p53 trans-activation domain progressed to become integrated into a range of cellular pathways. We discuss how a single synonymous mutation in the BOX-1, the p53(L22 L), observed in a chronic lymphocyte leukaemia patient, prevents the activation of p53 following DNA damage. The concepts analysed and discussed in this review may serve as a conceptual mechanistic paradigm of the co-evolution and function of molecules having roles in cellular regulation, or the aetiology of genetic diseases and how synonymous mutations can affect the encoded protein.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 12
- $a regulace genové exprese u nádorů $7 D015972
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory $x genetika $x metabolismus $x patologie $7 D009369
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a interakční proteinové domény a motivy $7 D054730
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a proteiny vázající RNA $x metabolismus $7 D016601
- 650 _2
- $a transkriptom $7 D059467
- 650 _2
- $a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
- 650 _2
- $a nádorové supresorové proteiny $x genetika $x metabolismus $7 D025521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Fåhraeus, Robin $u Université Paris 7, INSERM UMR 1131, 27 Rue Juliette Dodu, 75010, Paris, France. Department of Medical Biosciences, Umea University, SE-90185, Umea, Sweden. RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
- 773 0_
- $w MED00008171 $t BMC cancer $x 1471-2407 $g Roč. 19, č. 1 (2019), s. 915
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31519161 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200525093327 $b ABA008
- 999 __
- $a ok $b bmc $g 1524767 $s 1095965
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 19 $c 1 $d 915 $e 20190913 $i 1471-2407 $m BMC cancer $n BMC Cancer $x MED00008171
- LZP __
- $a Pubmed-20200511